Ozagrel Sodium | Interleukin Related interleukin-related.com

Product Name :
Ozagrel Sodium

Search keywords :
Ozagrel (sodium)

drugId :
null

Target Vo:
Thromboxane A2 synthase

Target Vo Short Name :
TBXAS1

Moa_Name:
Thromboxane A2 synthase inhibitors

First Approval Country :
Japan

First Approval Date Filter:
1988

Origin Company_Name :

Active Company_Name :
Dandong Medical Innovation Pharmaceutical Co Ltd

Active Indication_Name:
Cerebrovascular Disorders

In Active Indication_Name:
Sjogren-Larsson Syndrome

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Vitamin D Receptor Antibody custom synthesis
Hexokinase II Rabbit mAb medchemexpress
SRC1 Antibody: SRC1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 157 kDa, targeting to SRC1. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts